Mast cells and stress - A psychoneuroimmunological perspective

Journal of Clinical Psychopharmacology

Volumn 22, Issue 2, 2002, Pages 103-108

  Theoharides, Theoharis C ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ANAPHYLATOXIN; ARACHIDONIC ACID DERIVATIVE; BIOGENIC AMINE; CHEMOKINE; CONTRAST MEDIUM; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; CYTOKINE; DETERGENT; ENZYME; ESTRADIOL; FOOD ADDITIVE; FREE RADICAL; GLUTAMATE SODIUM; GROWTH FACTOR; IMMUNOGLOBULIN E; LOCAL ANESTHETIC AGENT; NEUROMUSCULAR BLOCKING AGENT; OPIATE DERIVATIVE; PARATHYROID HORMONE; PEPTIDE; PROTEOGLYCAN; TOXIN; UROCORTIN; XENOBIOTIC AGENT;

AFFECTIVE NEUROSIS; ASTHMA; ATOPIC DERMATITIS; COLD; EDITORIAL; ELECTROMAGNETIC RADIATION; ESCHERICHIA COLI; EXERCISE; FIBROMYALGIA; HUMAN; INTERSTITIAL CYSTITIS; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; MEASLES VIRUS; MIGRAINE; MULTIPLE SCLEROSIS; NEUROFIBROMATOSIS; NONHUMAN; PARAINFLUENZA VIRUS; PATHOPHYSIOLOGY; PRESSURE; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RHEUMATOID ARTHRITIS; SENDAI VIRUS; STRESS; ULTRAVIOLET RADIATION; UNSTABLE ANGINA PECTORIS;

CHILD; HUMANS; MAST CELLS; MASTOCYTOSIS; PSYCHONEUROIMMUNOLOGY; STRESS, PSYCHOLOGICAL;

EID: 0036215636     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-200204000-00001     Document Type: Editorial

References (96)

1. New insights into "the riddle of the mast cells" microenvironmental regulation of mast cell development and phenotypic heterogeneity
2. Allergy and depression: A neurochemical threshold model of the relation between the illnesses
3. Concordance of atopic and affective disorders
4. Allergic disorders in depressed patients
5. The relation of eczema to attitude and to vascular reactions of the human skin
6. Effects of allergy season on mood and cognitive function
7. Stress and illness
8. Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses
9. Stress and irritable bowel syndrome
10. Mast cell involvement in interstitial cystitis: A review of human and experimental evidence
11. Mast cell activation in children with migraine before and after training in self-regulation
12. Mast cell: A neuroimmunoendocrine master player
13. Recent advances in mastocytosis research. Summary of the Vienna mastocytosis meeting 1998
14. Pediatric mastocytosis
15. Mast cells in rat thalamus: Nuclear localization, sex difference and left-right asymmetry
16. The mast cells of the mammalian central nervous system. Part I. Morphology, distribution and histochemistry
17. Definitive characterization of rat hypothalamic mast cells
18. New concepts about the mast cell
19. Involvement of calcium in exocytosis and the exocytosis-vesiculation sequence
20. Mediators of human mast cells and human mast cell subsets
21. Mediators of immediate hypersensitivity reactions
22. Differential release of serotonin and histamine from mast cells
23. Vesicular transport of histamine in stimulated human basophils
24. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli
25. Differential release of mast cell interleukin-6 via c-kit
26. Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation
27. Piecemeal degranulation of mast cells in the inflammatory eyelid lesions of interleukin-4 transgenic mice. Evidence of mast cell histamine release in vivo by diamine oxidase-gold enzyme-affinity ultrastructiral cytochemistry
28. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis
29. Suggestive evidence for a direct innervation of mucosal mast cells
30. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves
31. Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo
32. Neuropeptides and the pathogenesis of allergy
33. Neuropeptide regulation of the expression of immediate hypersensitivity
34. Neuropeptides, mast cells and allergy: Novel mechanisms and therapeutic possibilities
35. Opiates, mast cells and histamine release
36. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro
37. Chondroitin sulfate as a regulator of neuronal patterning in the retina
38. Characterization of a factor that promotes neurite outgrowth: Evidence linking activity to a heparan sulfate proteoglycan
39. New hope for neurofibromatosis? The mast cell connection
40. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells
41. Influence of the sympathetic nervous system as well as trigeminal sensory fibres on rat dural mast cells
42. Plasma protein extravasation induced in the rat dura mater by stimulation of the parasympathetic sphenopalatine ganglion
43. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect
44. Mediators of blood-brain barrier dysfunction and formation of vasogenic brain edema
45. Inflammatory mediators and modulation of blood-brain barrier permeability
46. The blood-brain barrier in neuroinflammatory diseases
47. Brain mast cell degranulation regulates blood-brain barrier
48. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells
49. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis
50. Mast cells and migraines
51. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients
52. Trauma to the central nervous system may result in formation or enlargement of multiple sclerosis plaques
53. The relationship of MS to physical trauma and psychological stress
54. The role of psychological process in a somatic disorder: Multiple sclerosis. 1. The emotional setting of illness onset and exacerbation
55. Psychological stress and the subsequent appearances of new brain MRI lesions in MS
56. Estradiol augments while tamoxifen inhibits rat mast cell secretion
57. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process
58. Cardiac mast cells are increased in apolipoprotein E knockout mice that develop atherosclerosis and release histamine with acute stress
59. Stress-induced interleukin-6 release in mice is mast cell-dependent and also involves cardiomyocytes stimulated by urocortin
60. 3-receptors: A new frontier in myocaridal ischemia
61. The pathophysiologic roles of interleukin-6 in human disease
62. Expression of angiotensin II and interleukin-6 in human coronary atherosclerotic plaques
63. Silent myocardial ischaemia due to mental stress
64. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease
65. Mental stress-induced myocardial ischemia and cardiac events
66. Stress-induced bladder mast cell activation: Implications for interstitial cystitis
67. Colonic mucin release in response to immobilization stress is mast cell dependent
68. Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans
69. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation
70. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects
71. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors
72. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: A link to neurogenic skin disorders
73. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress
74. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors
75. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress
76. The intracerebroventicularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats
77. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs
78. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans
79. CRH and the immune system
80. Differential release of serotonin without comparable histamine under diverse conditions in the rat mast cell
81. Inhibition of mouse mast cell proliferation and proinflammatory mediator release by benzodiazepines
82. 3H] diazepam binding to rat peritoneal mast cells
83. High affinity benzodiazepine receptors on rat peritoneal mast cells and RBL-1 cells: Binding characteristics and effects on granule secretion
84. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation
85. Effect of hydroxyzine on morphine analgesia for the treatment of postoperative pain
86. A pilot, double-blind, study using hydroxyzine in remitting-relapsing multiple sclerosis (RR-MS)
87. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease and cancer
88. Chondroitin sulfate inhibits connective tissue mast cells
89. Mast cells: The immune gate to the brain
90. Skin mast cells: The universal sensor of environmental and emotional stress
91. Mast cells and the nerves - Potential interactions in the context of chronic disease
92. Mast cells in the brain: Evidence and functional significance
93. Mast cell interactions with the nervous system: Relationship to mechanisms of disease
94. The diverse roles of mast cells